Strides Pharma schedules an earnings call for May 18, 2026, to discuss its audited Q4 and FY26 results.
Managing Director Badree Komandur and Group CFO Vikesh Kumar will host the conference call for investors.
The event is a group meet for analysts and investors, with dial-in details and a pre-registration link provided.
The company confirms no unpublished price sensitive information will be shared during the scheduled interaction.